These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 10885605)

  • 1. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
    Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
    Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location.
    Gervaz P; Bouzourene H; Cerottini JP; Chaubert P; Benhattar J; Secic M; Wexner S; Givel JC; Belin B
    Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mutations, acetylator status, and prognosis in colorectal cancer.
    Hardingham JE; Butler WJ; Roder D; Dobrovic A; Dymock RB; Sage RE; Roberts-Thomson IC
    Gut; 1998 May; 42(5):669-72. PubMed ID: 9659162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
    Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
    Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival.
    Dix BR; Robbins P; Soong R; Jenner D; House AK; Iacopetta BJ
    Int J Cancer; 1994 Dec; 59(6):747-51. PubMed ID: 7989112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous mutations in K-ras and TP53 are indicative of poor prognosis in sporadic colorectal cancer.
    González-Aguilera JJ; Oliart S; Azcoita MM; Fernández-Peralta AM
    Am J Clin Oncol; 2004 Feb; 27(1):39-45. PubMed ID: 14758132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma.
    Conlin A; Smith G; Carey FA; Wolf CR; Steele RJ
    Gut; 2005 Sep; 54(9):1283-6. PubMed ID: 15843421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers.
    Wang JY; Hsieh JS; Chang MY; Huang TJ; Chen FM; Cheng TL; Alexandersen K; Huang YS; Tzou WS; Lin SR
    World J Surg; 2004 Jul; 28(7):721-6. PubMed ID: 15185002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer.
    Gnanasampanthan G; Elsaleh H; McCaul K; Iacopetta B
    J Pathol; 2001 Dec; 195(5):543-8. PubMed ID: 11745689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of proliferative activity, DNA-ploidy, p53 and Ki-ras point mutations in colorectal liver metastases.
    Russo A; Migliavacca M; Bazan V; Maturi N; Morello V; Dardanoni G; Modica G; Bazan P; Albanese I; La Farina M; Tomasino RM
    Cell Prolif; 1998; 31(3-4):139-53. PubMed ID: 9853427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer.
    Bleeker WA; Hayes VM; Karrenbeld A; Hofstra RM; Hermans J; Buys CC; Plukker JT
    Am J Gastroenterol; 2000 Oct; 95(10):2953-7. PubMed ID: 11051374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.
    Dergham ST; Dugan MC; Kucway R; Du W; Kamarauskiene DS; Vaitkevicius VK; Crissman JD; Sarkar FH
    Int J Pancreatol; 1997 Apr; 21(2):127-43. PubMed ID: 9209954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
    Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
    J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-mutation of p53, K-ras genes and accumulation of p53 protein and its correlation to clinicopathological features in rectal cancer.
    Pan ZZ; Wan DS; Chen G; Li LR; Lu ZH; Huang BJ
    World J Gastroenterol; 2004 Dec; 10(24):3688-90. PubMed ID: 15534934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 alterations are associated with improved prognosis in distal colonic carcinomas.
    Soong R; Grieu F; Robbins P; Dix B; Chen D; Parsons R; House A; Iacopetta B
    Clin Cancer Res; 1997 Aug; 3(8):1405-11. PubMed ID: 9815825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel method for simultaneous analysis of p53 and K-ras mutations and p53 protein expression in single histologic sections.
    Yamashita K; Yoshida T; Shinoda H; Okayasu I
    Arch Pathol Lab Med; 2001 Mar; 125(3):347-52. PubMed ID: 11231481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation.
    Soong R; Powell B; Elsaleh H; Gnanasampanthan G; Smith DR; Goh HS; Joseph D; Iacopetta B
    Eur J Cancer; 2000 Oct; 36(16):2053-60. PubMed ID: 11044641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.